SHARE Adaptation Intervention for African-American Families

Conditions

• Mild Dementia
• Moderate Dementia

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• 5+1 Adapted, early-stage dyadic care planning intervention — BEHAVIORAL
  The intervention group will receive the adapted SHARE Dyadic program, consisting of five, 60-90-minute curriculum-guided sessions with a SHARE Counselor, plus one optional family session.
• Counseling session and printed resources — BEHAVIORAL
  Control group participants will receive a treatment as usual equivalent: a single, standardized educational and resource session with a packet of information.

Study Details

This project aims to culturally adapt the SHARE program for African-Americans in early-moderate stage dementia and their care partner. Upon completion of the adaptation, a pilot randomized-control trial wil be confucted to compare the adaptaed SHARE program versus usual care.

Key Dates

Start date

Aug 19, 2025

Status verified

Aug 2025

Primary completion

Mar 30, 2026

Completion

Jul 31, 2026

Study Design

Enrollment

120 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Arms

• Experimental: Treatment (SHARE Dyadic Intervention)
  Treatment group dyads are comprised of a PLWD with mild to moderate dementia and his/her preferred CG. Following recruitment and the consent process and screening, baseline telephone interviews (T1) with trained interviewers from the Benjamin Rose Institute on Aging will be completed separately with all CGs and PLWDs. Treatment group dyads will receive the culturally adapted SHARE intervention compromised of up to five, 60- 90-minute, curriculum-guided sessions with a SHARE Counselor over a 8-10 week period. A (T2) follow-up interview will be conducted approximately two weeks after treatment group dyads complete their final session;.
• Active Comparator: Control (Treatment as usual single session)
  Control group dyads are comprised of a PLWD with mild to moderate dementia and his/her preferred CG. Following recruitment and the consent process and screening, baseline telephone interviews (T1) with trained interviewers from the Benjamin Rose Institute on Aging will be completed separately with all CGs and PLWDs. Control group participants will receive a treatment as usual equivalent: a standardized educational and resource single session with a packet of information. A (T2) follow-up interview will be conducted approximately approximately eight weeks after (T1) baseline interviews.

Primary Outcome Measure

Session length [ Time Frame: After each session; within 10 weeks of baseline. ]

Central Contacts

• Silvia Orsulic-Jeras
  2163731625
  [email protected]
• Zoe Fete
  2163731929
  [email protected]

Locations (1)

Find similar trials in Cleveland, OH

Related Studies

• Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
  PHASE1 · Recruiting · Butler Hospital · Los Angeles, California
• Transcranial Pulse Stimulation of the Brain
  Recruiting · University of Florida · Gainesville, Florida
• Activity Tracking, Care Partner Co-participation, Text Reminders, Instructional Education, Video-Guided Physical Rehabilitation, and Exercise
  Recruiting · NYU Langone Health · New York, New York